Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 145617, 5 pages
http://dx.doi.org/10.1155/2011/145617
Clinical Study

The Gap between Tobacco Treatment Guidelines, Health Service Organization, and Clinical Practice in Comprehensive Cancer Centres

1Patient Information Services, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
2Tobacco Control Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
3Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
4Società Italiana di Medicina Generale, 50142 Florence, Italy
5Scientific Direction, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
6Tobacco Control Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy

Received 15 December 2010; Revised 21 March 2011; Accepted 13 May 2011

Academic Editor: Sushant Kachhap

Copyright © 2011 R. Mazza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Swartz Woods and C. R. Jaen, “Increasing consumer demand for Tobacco Treatments. Ten recommendations for clinicians and healthcare systems,” American Journal of Preventive Medicine, vol. 38, no. 3, pp. S385–S392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Demark-Wahnefried, N. M. Aziz, J. H. Rowland, and B. M. Pinto, “Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer,” Journal of Clinical Oncology, vol. 23, no. 24, pp. 5814–5830, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, “Report on the global tobacco epidemic,” Tech. Rep., The mPower Package, 2009, http://www.who.int/tobacco/mpower/en/. View at Google Scholar
  4. V. Aboyans, D. Thomas, and P. Lacroix, “The cardiologist and smoking cessation,” Current Opinion in Cardiology, vol. 25, no. 5, pp. 469–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Mazza, M. Lina, R. Boffi, G. Invernizzi, C. De Marco, and M. Pierotti, “Taking care of smoker cancer patients: a review and some recommendations,” Annals of Oncology, vol. 21, no. 7, pp. 1404–1409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tønnesen, L. Carrozzi, K. O. Fagerström et al., “Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy,” European Respiratory Journal, vol. 29, no. 2, pp. 390–417, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Møller and H. Tønnesen, “Risk reduction: perioperative smoking intervention,” Best Practice and Research: Clinical Anaesthesiology, vol. 20, no. 2, pp. 237–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Invernizzi, A. Ruprecht, C. De Marco, R. Mazza, G. Nicolini, and R. Boffi, “Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance,” Respiratory Research, vol. 10, p. 48, 2009. View at Google Scholar · View at Scopus
  9. D. J. Tollerud, J. W. Clark, L. M. Brown et al., “Association of cigarette smoking with decreased numbers of circulating natural killer cells,” American Review of Respiratory Disease, vol. 139, no. 1, pp. 194–198, 1989. View at Google Scholar · View at Scopus
  10. L. Arcavi and N. L. Benowitz, “Cigarette smoking and infections,” Archives of Internal Medicine, vol. 164, no. 20, pp. 2206–2216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. “Il fumo in ItaliaIl Italia,” 2010, http://www.iss.it/binary/fumo/cont/fumo_2010_long.pdf.
  12. http://www.iss.it/binary/publ/cont/10S1WEB.pdf.
  13. “HPH Italian National Conference, Proceedings, Milan October 2008”.
  14. P. Boffetta, M. Tubiana, C. Hill et al., “The causes of cancer in France,” Annals of Oncology, vol. 20, no. 3, pp. 550–555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Samant and T. L. Tucker, “Analysis of cigarette smoking habits of cancer patients referred to the Northeastern Ontario Regional Cancer Centre,” Journal of Cancer Education, vol. 18, no. 3, pp. 157–160, 2003. View at Google Scholar · View at Scopus
  16. A. Theadom and M. Cropley, “Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review,” Tob Control, vol. 15, pp. 352–358, 2006. View at Google Scholar
  17. J. Xu, H. Huang, C. Pan et al., “Nicotine inhibits apoptosis induced by cisplatin human oral cancer cells,” International Journal of Oral and Maxillofacial Surgery, vol. 36, pp. 739–44, 2007. View at Google Scholar
  18. J. M. Van der Bol, R. H. J. Mathijssen, W. J. Loos et al., “Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia,” Journal of Clinical Oncology, vol. 25, no. 19, pp. 2719–2726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. P. Browman, G. Wong, I. Hodson et al., “Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer,” The New England Journal of Medicine, vol. 328, no. 3, pp. 159–163, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Pao, V. Miller, M. Zakowski et al., “EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 36, pp. 13306–13311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Daley, R. Begh, and P. Aveyard, “Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis,” British Medical Journal, vol. 340, no. 7740, p. 251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. I. Booi, I. B. Debats, W. D. Boeckx, and R. R. van der Hulst, “Risk factors and blood flow in the free transverse rectus abdominis (TRAM) flap: smoking and high flap weight impair the free TRAM flap microcirculation,” Annals of Plastic Surgery, vol. 59, no. 4, pp. 364–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Leithead, J. W. Ferguson, and P. C. Hayes, “Smoking-related morbidity and mortality following liver transplantation,” Liver Transplantation, vol. 14, no. 8, pp. 1159–1164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. McConathy, V. Turner, T. Johnston et al., “Analysis of smoking in patients referred for liver transplantation and its adverse impact of short-term outcomes,” The Journal of the Kentucky Medical Association, vol. 105, no. 6, pp. 261–266, 2007. View at Google Scholar · View at Scopus
  25. L. T. Sorensen, T. Jørgensen, L. T. Kirkeby, J. Skovdal, B. Vennits, and P. Wille-Jørgensen, “Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery,” British Journal of Surgery, vol. 86, no. 7, pp. 927–931, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. S. L. Ehlers, D. A. Gastineau, C. A. Patten et al., “The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia,” Bone Marrow Transplantation, vol. 46, pp. 285–290, 2010. View at Publisher · View at Google Scholar
  27. M. C. Fiore, C. R. Jaén, T. B. Baker et al., Treating Tabacco Use and Dependance, Clinical Practical Guideline, Department of Health and Human Services. Public Health Service, Rockville, Md, USA, 2008.
  28. R. A. Schnoll, E. Martinez, K. L. Tatum et al., “A bupropion smoking cessation clinical trial for cancer patients,” Cancer Causes and Control, vol. 21, no. 6, pp. 811–820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. S. Cox, N. L. Africano, K. P. Tercyak, and K. L. Taylor, “Nicotine dependence treatment for patients with cancer. Review and recommendations,” Cancer, vol. 98, no. 3, pp. 632–644, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. AIRTUM Working Group, “Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Report 2010,” Epidemiologia E Prevenzione, vol. 34, no. 5-6, pp. 1–188, 2010. View at Google Scholar
  31. M. G. Ficarra, M. R. Gualano, S. Capizzi et al., “Tobacco use prevalence, knowledge and attitudes among Italian hospital healthcare professionals,” European Journal of Public Health, vol. 21, no. 1, pp. 29–34, 2010. View at Google Scholar
  32. C. A. Jimenez-Ruiz, M. M. Ulibarri, N. A. Besada, A. C. Guerrero, A. G. Garcia, and A. R. Cuadrado, “Progressive reduction using nicotine gum as a prelude to quitting,” Nicotine and Tobacco Research, vol. 11, no. 7, pp. 847–850, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. R. D. Pentz and C. J. Berg, “Smoking and ethics,” Oncologist, vol. 15, no. 9, pp. 987–993, 2010. View at Publisher · View at Google Scholar · View at Scopus